ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
⏸️ ASX Shares
Investing $1,000 in these 3 ASX shares could be a very smart move
⏸️ ASX Shares
3 five-star ASX shares to buy next week
Share Market News
ASX 200 down 0.2%: Big four banks drop, CIMIC jumps, CSL slides lower
⏸️ ASX Shares
Is the ResMed (ASX:RMD) share price a strong buy today?
How to invest
You could become very wealthy by investing $1,000 into these ASX shares
Share Market News
Potential ASX winners from government's $1.5bn manufacturing blueprint
⏸️ ASX Shares
2 must-buy ASX 200 shares I rate highly
⏸️ ASX Shares
3 of the best ASX healthcare shares to buy and hold
⏸️ ASX Shares
10 fantastic ASX shares to buy in October
Growth Shares
3 fantastic ASX shares to buy in October
Share Market News
How to turn $20,000 into over $200,000 in 10 years with ASX shares
Growth Shares
Why I would buy Altium (ASX:ALU) and these ASX growth shares
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
